Inverse correlation between galectin-4 and TTF-1 in lung adenocarcinoma

[1]  F. Hirsch,et al.  New and emerging targeted treatments in advanced non-small-cell lung cancer , 2016, The Lancet.

[2]  Joan Minguet,et al.  Targeted therapies for treatment of non‐small cell lung cancer—Recent advances and future perspectives , 2016, International journal of cancer.

[3]  A. Nicholson,et al.  Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  G. Rabinovich,et al.  Assembly, organization and regulation of cell-surface receptors by lectin-glycan complexes. , 2015, The Biochemical journal.

[5]  Tsuyoshi Saito,et al.  Skeletal Metastasis of Unknown Primary Origin at the Initial Visit: A Retrospective Analysis of 286 Cases , 2015, PloS one.

[6]  Y. Murakumo,et al.  Diagnostic and Prognostic Significances of MUC5B and TTF-1 Expressions in Resected Non-Small Cell Lung Cancer , 2015, Scientific Reports.

[7]  T. Mitsudomi.  Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutations. , 2014, Translational lung cancer research.

[8]  T. Hensing,et al.  Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung , 2014, Oncoscience.

[9]  M. F. Troncoso,et al.  Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma. , 2013, World journal of gastroenterology.

[10]  Kenji Suzuki,et al.  Galectin-4, a Novel Predictor for Lymph Node Metastasis in Lung Adenocarcinoma , 2013, PloS one.

[11]  A. Burke,et al.  Histologic Features Associated With Metastatic Potential in Invasive Adenocarcinomas of the Lung , 2013, The American journal of surgical pathology.

[12]  M. Ladanyi,et al.  KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma , 2013, Modern Pathology.

[13]  Y. Kajiyama,et al.  Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas. , 2012, Human pathology.

[14]  Prasad S Adusumilli,et al.  A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma , 2012, Modern Pathology.

[15]  C. Chen,et al.  Serum Galectin-2, -4, and -8 Are Greatly Increased in Colon and Breast Cancer Patients and Promote Cancer Cell Adhesion to Blood Vascular Endothelium , 2011, Clinical Cancer Research.

[16]  M. Mori,et al.  Clinical significance of circulating galectins as colorectal cancer markers. , 2011, Oncology reports.

[17]  M. Copin,et al.  The mouse Muc5b mucin gene is transcriptionally regulated by thyroid transcription factor‐1 (TTF‐1) and GATA‐6 transcription factors , 2011, The FEBS journal.

[18]  L. Chirieac,et al.  Prognostic significance of grading in lung adenocarcinoma , 2010, Cancer.

[19]  Y. Ishikawa,et al.  Is the epidermal growth factor receptor status in lung cancers reflected in clinicopathologic features? , 2010, Archives of pathology & laboratory medicine.

[20]  V. Capelozzi,et al.  Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma. , 2009, Lung cancer.

[21]  Y. Ishikawa,et al.  EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset , 2009, Modern Pathology.

[22]  G. Bepler,et al.  Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  M. Meyerson,et al.  TTF1 expression in non‐small cell lung carcinoma: association with TTF1 gene amplification and improved survival , 2009, The Journal of pathology.

[24]  Yuki Togashi,et al.  EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[25]  Y. Yatabe,et al.  TTF-1 Expression in Pulmonary Adenocarcinomas , 2002, The American journal of surgical pathology.

[26]  Roman Kodet,et al.  Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases , 2002, Virchows Archiv.

[27]  J. Whitsett,et al.  GATA-6 and Thyroid Transcription Factor-1 Directly Interact and Regulate Surfactant Protein-C Gene Expression* , 2002, The Journal of Biological Chemistry.

[28]  H. Aburatani,et al.  Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. , 2001, Cancer research.

[29]  R. Hughes.  Secretion of the galectin family of mammalian carbohydrate-binding proteins. , 1999, Biochimica et biophysica acta.

[30]  A. Ryo,et al.  Identification and characterization of genes associated with human hepatocellular carcinogenesis. , 1999, Cancer research.

[31]  B. Stripp,et al.  Regulation of Clara cell secretory protein gene transcription by thyroid transcription factor-1. , 1997, Biochimica et biophysica acta.

[32]  R. Schwartz,et al.  Transcriptional regulation of a mouse Clara cell-specific protein (mCC10) gene by the NKx transcription factor family members thyroid transciption factor 1 and cardiac muscle-specific homeobox protein (CSX) , 1996, Molecular and cellular biology.

[33]  W. Travis.  WHO classification of tumours of the lung, pleura, thymus and heart , 2015 .

[34]  阿不都卡的 依马木.  Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas , 2012 .

[35]  J. Silverman,et al.  Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. , 2004, Human pathology.